Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Surgical & Medical Instruments & Apparatus

Zimmer Biomet Holdings, Inc. to acquire Monogram Technologies Inc.

Announced Jul 14, 2025 · Closed Oct 7, 2025

Deal value$177MEV $164M
Premium22.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$4.04 per share

Transaction

Acquirer
Zimmer Biomet Holdings, Inc. (ZBH)
Target
Monogram Technologies Inc. (MGRM)
Buyer type
Strategic
Offer price per share
$4.04
Enterprise value
$164M
Status
Closed Oct 7, 2025

Deal protections

Break fee (target pays)
$11.0M · 6.2%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Morgan Stanley
To the target
Wells Fargo
Wells Fargo fee
$8.7M

Sector context · Healthcare

Comparable deals
94 in the prior 24 months
Premium
22.0% vs. 67.0% sector median
EV / Adj. EBITDA
Sector median 13.8x
Break fee
6.2% vs. 3.4% sector median

Timeline

  1. AnnouncedJul 14, 2025
  2. Proxy filedAug 11, 2025
  3. Definitive proxyAug 28, 2025
  4. Shareholder voteSep 30, 2025
  5. ClosedOct 7, 2025

Valuation · fairness opinions

Discounted cash flow$1.38$2.90
Offer $4.04

Implied value per Monogram Technologies Inc. share by analysis, from Wells Fargo.

Sources
  • DEFA14A (EX-99.2) · Jul 14, 2025
  • 8-K · Jul 14, 2025
  • 8-K · Aug 28, 2025
  • 8-K (EX-99.1) · Oct 7, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.